Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

Mannino, D.M.; Buist, A.S.; Petty, T.L.; Enright, P.L.; Redd, S.C.
May 2003
Thorax;May2003, Vol. 58 Issue 5, p388
Academic Journal
Background: A study was undertaken to define the risk of death among a national cohort of US adults both with and without lung disease. Methods: Participants in the first National Health and Nutrition Examination Survey (NHANES I) followed for up to 22 years were studied. Subjects were classified using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria for chronic obstructive pulmonary disease (COPD) into the following mutually exclusive categories using the forced expiratory volume in 1 second (FEV[sub 1]), forced vital capacity (FVC), FEV[sub 1]/FVC ratio, and the presence of respiratory symptoms: severe COPD, moderate COPD, mild COPD, respiratory symptoms only, restrictive lung disease, and no lung disease. Proportional hazard models were developed that controlled for age, race, sex, education, smoking status, pack years of smoking, years since quitting smoking, and body mass index. Results: A total of 1301 deaths occurred in the 5542 adults in the cohort. In the adjusted proportional hazards model the presence of severe or moderate COPD was associated with a higher risk of death (hazard ratios (HR) 2.7 and 1.6, 95% confidence intervals (CI) 2.1 to 3.5 and 1.4 to 2.0), as was restrictive lung disease (HR 1.7, 95% CI 1.4 to 2.0). Conclusions: The presence of both obstructive and restrictive lung disease is a significant predictor of earlier death in long term follow up.


Related Articles

  • Patients with COPD: do we fail them from beginning to end? Partridge, M.R. // Thorax;May2003, Vol. 58 Issue 5, p373 

    Editorial. Recognizes the burden of chronic obstructive pulmonary disease (COPD) to both the individual and the society. Development of a comprehensive approach for the prevention and control of respiratory disease; Importance of diagnosing COPD early in its natural history.

  • Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Brusasco, V.; Hodder, R.; Miravitlles, M.; Korducki, L.; Towse, L.; Kesten, S. // Thorax;May2003, Vol. 58 Issue 5, p399 

    Background: A study was undertaken to record exacerbations and health resource use in patients with COPD during 6 months of treatment with tiotropium, salmeterol, or matching placebos. Methods: Patients with COPD were enrolled in two 6-month randomised, placebo controlled, double blind, double...

  • COPD: Management of Acute Exacerbation and Chronic Stable Disease. Hunter, Melissa H.; King, Dana E. // American Family Physician;8/15/2001, Vol. 64 Issue 4, p603 

    Acute exacerbations of chronic obstructive pulmonary disease (COPD) are treated with oxygen (in hypoxemic patients), inhaled beta2 agonists, inhaled anticholinergics, antibiotics and systemic corticosteroids. Methylxanthine therapy may be considered in patients who do not respond to other...

  • End-stage COPD. Fernandes, Tanya // Nursing Standard;10/10/2012, Vol. 27 Issue 6, p58 

    A quiz on end stage chronic obstructive pulmonary disease is presented.

  • Ultrafine Particles in Human Lung Macrophages. Hauser, Russ; Godleski, John J.; Hatch, Victoria; Christiani, David C. // Archives of Environmental Health;Mar/Apr 2001, Vol. 56 Issue 2, p150 

    ABSTRACT. As knowledge about size dependency of particle toxicity continues to grow, attention has been focused on ultrafine particles (i.e., < 0.1 micro m in diameter). In recent studies with rats, investigators learned that ultrafine particles likely have greater pulmonary toxicity than larger...

  • Coping Behaviors of Individuals With Chronic Obstructive Pulmonary Disease. Chien-yun Wu; Yan-Yal Lee; Baig, Karin; Ora-anong Wichaikhum // MEDSURG Nursing;Dec2001, Vol. 10 Issue 6, p315 

    Presents a study which examined the coping behaviors of patients with chronic obstructive pulmonary disease. Methods; Results; Discussion.

  • Chronic obstructive pulmonary disease.  // Nursing Standard;1/30/2008, Vol. 22 Issue 21, p58 

    A quiz concerning chronic obstructive pulmonary disease is presented.

  • Authors' response to Young and Hopkins: vitamin D and lung function. Afzal, Shoaib; Lange, Peter; Bojesen, Stig E.; Freiberg, Jacob J.; Nordestgaard, Børge G. // Thorax;Aug2014, Vol. 69 Issue 8, p770 

    A response from the author of the article "Plasma 25 hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease" in the 2014 issue is presented.

  • Chronic Obstructive Pulmonary Disease Surveillance-- United States, 1971-2000. Mannino, David M.; Homa, David M.; Ford, Earl S.; Redd, Stephen C.; Akinbami, Lara J. // MMWR: Morbidity & Mortality Weekly Report;8/2/2002 Supplement, Vol. 51 Issue 30, p1 

    Presents data in the U.S. regarding chronic obstructive pulmonary disease (COPD) during the period between 1971 and 2000. COPD-associated activity and functional limitations between 1980 and 1996; Self-reported COPD prevalence; COPD physician office and hospital outpatient department visits.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics